Indocyanine Green (ICG) and Colorectal Surgery: A Literature Review on Qualitative and Quantitative Methods of Usage
Overview
Authors
Affiliations
: Due to its many benefits, indocyanine green (ICG) has gained progressive popularity in operating rooms (ORs) globally. This literature review examines its qualitative and quantitative usage in surgical treatment. : Relevant terms were searched in five international databases (1. Pubmed, 2. Sciencedirect, 3. Scopus, 4. Oxfordjournals, 5. Reaxys) for a comprehensive literature review. The main benefits of using ICG in colorectal surgery are: intraoperative fluorescence angiography; fluorescence-guided lymph node involvement detection and the sentinel technique; the fluorescent emphasis of a minute liver tumour, counting just 200 tumour cells; facilitation of fistula diagnosis; and tumour tattooing. This methodology can also be used with quantitative characteristics such as maximum intensity, relative maximum intensity, and in-flow parameters such as time-to-peak, slope, and t1/2max. This article concludes that fluorescence surgery with ICG and near-infrared (NIR) light is a relatively new technology that improves anatomical and functional information, allowing more comprehensive and safer tumour removal and the preservation of important structures.
Biomarkers in Colorectal Cancer: Actual and Future Perspectives.
Liscu H, Verga N, Atasiei D, Badiu D, Dumitru A, Ultimescu F Int J Mol Sci. 2024; 25(21).
PMID: 39519088 PMC: 11546354. DOI: 10.3390/ijms252111535.
Agnesi S, Virgilio F, Frontali A, Zoni G, Giugliano M, Missaglia C Int J Colorectal Dis. 2024; 39(1):174.
PMID: 39466460 PMC: 11519083. DOI: 10.1007/s00384-024-04746-0.
Rotaru V, Chitoran E, Zob D, Ionescu S, Aisa G, Andra-Delia P Diagnostics (Basel). 2024; 14(16).
PMID: 39202196 PMC: 11353817. DOI: 10.3390/diagnostics14161707.
Developments in the Use of Indocyanine Green (ICG) Fluorescence in Colorectal Surgery.
Khalafi S, Botero Fonnegra C, Reyes A, Hui V J Clin Med. 2024; 13(14).
PMID: 39064041 PMC: 11276973. DOI: 10.3390/jcm13144003.
Bevacizumab-Based Therapies in Malignant Tumors-Real-World Data on Effectiveness, Safety, and Cost.
Chitoran E, Rotaru V, Ionescu S, Gelal A, Capsa C, Bohiltea R Cancers (Basel). 2024; 16(14).
PMID: 39061228 PMC: 11274419. DOI: 10.3390/cancers16142590.